Peter Cass, OD
Optometrist · Beaumont, TXNPI 1306893144
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Alcon accounts for 72.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $3,485 and has fallen 95.6% since, to $155 in 2025. Among optometrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $74.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$5K
- Bausch & Lomb Americas Inc.$395
- AbbVie$341
- Bausch & Lomb, A Division Of Bausch Health US, LLC$284
- Coopervision Inc.$231
- Oyster Point Pharma, Inc.$122
- plus $414 from 10 others
Across 151 payments — averaging $654.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$99K
What the payments were for
- Consulting fees$63010%
- Speaking & faculty fees$2,31035%
- Travel & lodging$1,10817%
- Food & beverage$2,49638%
- Education$180%
- Entertainment$371%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 28 | $4,811 |
| Bausch & Lomb Americas Inc. | 14 | $395 |
| AbbVie(2 entities) | 7 | $341 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $284 |
| Coopervision Inc. | 4 | $231 |
| Oyster Point Pharma, Inc. | 2 | $122 |
| Johnson & Johnson Vision Care, Inc. | 4 | $96 |
| ABB Con-cise Optical Group LLC | 2 | $95 |
| Carl Zeiss Meditec, Inc. | 1 | $47 |
| Optovue, Inc. | 1 | $41 |
| Optos, Inc. | 1 | $37 |
| Tarsus Pharmaceuticals, Inc. | 1 | $30 |
| Shire North American Group Inc | 1 | $27 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Biotissue Holdings Inc. | 1 | $14 |
| Maculogix, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Precision 1$2,310
- DAILIES$1,205
- AIR OPTIX$537
- RESTASIS$132
- INFUSE MULTIFOCAL$125
- MyDay Contact Lens$113
- LUMIGAN$111
How this compares
$6,598 in reported general payments places this provider in the 90th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lotemax SmLoteprednol Etabonate | 15 | $3,797 |
| Brimonidine Tartrate | 18 | $2,056 |
| Loteprednol Etabonate | 13 | $1,152 |
| Bepotastine Besilate | 11 | $710 |
| Latanoprost | 84 | $696 |
| MoxifloxacinMoxifloxacin Hcl | 12 | $238 |
| Timolol Maleate | 19 | $155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm, Loteprednol Etabonate | $284 | $4,94928 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,315 optometrist providers in Texas.
Other optometrist in Beaumont
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
- Richard PotvinBurleson$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.